News Headlines

  1. DINAMIQS Opens cGMP Manufacturing Facility For Viral Vectors 9/29/2025

    DINAMIQS, a Siegfried company, today inaugurated its state-of-the-art cGMP manufacturing facility for viral vectors — the first of its kind in Switzerland.

  2. AbbVie Breaks Ground On New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility 9/29/2025

    AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. This is a significant milestone in AbbVie's ongoing efforts to expand its U.S. manufacturing network, capabilities and capacity.

  3. Locus Cell's Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU With Cambium Bio 9/29/2025

    Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium Bio (ASX: CMB).

  4. Rezon Bio Launches As A European Biologics CDMO Combining Cost Efficiency And Digital Innovation 9/29/2025

    Rezon Bio today announced its launch as a European contract development and manufacturing organization (CDMO) for biologics. It enters the market as a new brand, but builds on a proven legacy of advancing biologics from gene to global commercialization through established partners.

  5. Health Hope Pharma Enters Into Exclusive Licensing Agreement With Gilead Sciences 9/29/2025

    Health Hope Pharma Limited ("HHP") today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology.

  6. Wombat Capital Markets Advised Regis Technologies On Its Sale To Esteve 9/26/2025

    This strategic move allows ESTEVE CDMO a physical presence in the U.S., expanding its contract development and manufacturing solutions for innovative small-molecule APIs across the entire drug development lifecycle from pre-clinical to commercial manufacturing.

  7. Amgen Announces $650M Expansion Of U.S. Manufacturing, Creating Hundreds Of New JobS 9/26/2025

    Amgen (NASDAQ: AMGN) today announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs.

  8. Praxis Packaging Solutions Expands With Acquisition Of Advanced Concept Innovations, LLC 9/25/2025

    The strategic combination with ACI further enhances Praxis’ customer oPering by broadening Praxis’ geographic footprint into the Southeastern United States, expanding its capabilities and market segments.

  9. Avant Technologies, Inc. Bolsters Strategic Vision With Targeted Biotech Partnerships For Innovative Cell-Based Therapies 9/25/2025

    Avant Technologies Inc. (OTCQB: AVAI) ("Avant" or the "Company"), today announced a pivotal evolution in its business direction, emphasizing strategic partnerships through joint ventures and licensing agreements to advance treatments for a range of chronic and age-related conditions.

  10. New Partnership Brings Next-Generation Cell Isolation Solutions To Researchers Advancing Cell And Gene Therapy Development 9/25/2025

    Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to expand access to Akadeum's next-generation cell isolation technology for cell and gene therapy development.